Forxiga met primary endpoint in T2NOW Phase III trial, one of the largest paediatric type 2 diabetes studies performed to date Read more
Japan’s Ministry of Health, Labour and Welfare approves GSK’s Arexvy, the country’s first respiratory syncytial virus (RSV) vaccine for older adults Read more
FDA Accepts for Priority Review Merck’s Supplemental New Drug Application for WELIREG (belzutifan) in Certain Previously Treated Patients With Advanced Renal Cell Carcinoma (RCC) Read more
European Commission Approves Pfizer’s LITFULO for Adolescents and Adults With Severe Alopecia Areata Read more
BioNTech and CEPI Announce Partnership to Advance mRNA Mpox Vaccine Development and Support CEPI’s 100 Days Mission Read more
AbCellera Announces Collaboration with Incyte to Accelerate the Discovery and Development of Therapeutic Antibodies in Oncology Read more
Takeda Announces FDA Acceptance of BLA for Subcutaneous Administration of ENTYVIO (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Crohn’s Disease Read more